February 04, 2026
"Modi-Trump Share a Very..." White House on India-U.S. Deal as BJP vs Congress at Home
In the wake of a high-octane year of tariff wars and diplomatic friction, a massive breakthrough has finally been reached: the India-US Trade Deal is officially here. But as the dust settles on the phone call between Prime Minister Narendra Modi and President Donald Trump, the world is asking—who actually walked away with the win? Join us as we decode the "father of all deals" that has slashed US tariffs on Indian goods from a staggering 50% down to 18%. We dive into the controversial trade-offs, including Trump’s claim that India has agreed to halt Russian oil imports and commit to a jaw-dropping $500 billion "Buy American" pledge. Did Modi’s strategic patience pay off, or did Trump’s "reciprocal tariff" pressure force a surrender? From the impact on Indian MSMEs and the sensitive agri-sector to the skepticism surrounding Trump’s "friendship-based" diplomacy, we analyze whether this deal is a sustainable "mega-partnership" or a temporary truce in a volatile era. CNAS program director Lisa Curtis discusses these issues with Barkha Dutt.
Watch the full interview on Mojo Story.
More from CNAS
-
Podcast
Defense / Indo-Pacific Security
Hellscape Taiwan: Drones, Deterrence, and the Future of Asymmetric DefenseStacie Pettyjohn joined the Irregular Warfare Podcast to examine how Taiwan could deter—or potentially defeat—a Chinese invasion by transforming the Taiwan Strait into an “unm...
By Stacie Pettyjohn
-
Video
Indo-Pacific Security / Energy, Economics & Security
Analysts Break Down Trump-Xi Meeting and Calls for Stability and CooperationFor perspective on President Trump's trip and the broader U.S.-China relationship, Geoff Bennett spoke with Myron Brilliant and Liza Tobin. Brilliant is at the DGA Group and i...
By Liza Tobin
-
Video
Indo-Pacific Security / Energy, Economics & Security
Rajdeep Sardesai Asks Big Question on US-ChinaThe debate on the Big Question, with Daniel Silverberg, adjunct senior fellow at the Center for a New American Security, explores whether Beijing holds the key to resolving th...
By Daniel Silverberg
-
China’s Pharmaceutical Weapon
Commentary
Until SAPIR is extended to biologically derived drugs, until the FDA clears the bovine pathway, and until at least one American-owned heparin manufacturer operates on US soil,...
By Jennifer Hendrixson White
